Analysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis After Revascularization

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 30

PMID 39076758

Authors

Zhuoxuan Yang

Tianjie Wang

Ying Dong

Long Liu

Xuan Xue

Jine Wu

Liuyi Hao

Jiansong Yuan

Jingang Cui

Shubin Qiao

Weixian Yang

Affiliations

Soon will be listed here.

Abstract

Background: To investigate the risk factors for myocardial infarction, recurrent in-stent restenosis (ISR) and target vessel revascularization (TVR) in patients with coronary ISR within 4 years after revascularization.

Methods: A total of 1884 patients who were hospitalized at Fuwai Hospital for ISR and successfully treated with coronary intervention between January 2017 and December 2018 were included to determine whether there were myocardial infarction, recurrent ISR, TVR and other major adverse cardiovascular events (MACEs) within 4 years after intervention. The patients were divided into the MACE group (215 patients) and the non-MACE group (1669 patients). The clinical data of patients in the two groups were compared, and the risk factors for postoperative MACEs in the ISR patients were obtained by multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve was used to determine the optimal prediction threshold for postoperative MACEs in ISR patients. The difference in survival curves between the two groups was compared using Kaplan‒Meier survival analysis.

Results: The albumin (43.42 4.77 vs. 44.17 4.46, = 0.021), direct bilirubin (2.5 (2, 3.5) vs. 2.8 (2.07, 3.73), = 0.036) and free triiodothyronine (FT3) (2.85 0.43 vs. 2.92 0.42, = 0.019) levels in the MACE group were significantly lower than those in the non-MACE group, and there was a significant negative correlation between albumin and FT3 and MACEs. The results of univariate and multivariate logistic regression analyses revealed that FT3 was an independent predictor of postoperative MACEs in ISR patients (Odds Ratio (OR) = 0.626, 95% CI: 0.429-0.913, = 0.015). The ROC curve analysis determined that an FT3 value of 2.785 pmol/L was the optimal prediction threshold. According to the threshold, ISR patients were divided into the FT3 2.785 group and the FT3 2.785 group. The Kaplan‒Meier analysis revealed that the postoperative recurrence rate of MACEs of the FT3 2.785 group was substantially greater than that of the FT3 2.785 group (Hazard Ratio (HR) = 0.76, 95% CI: 0.58-0.994, = 0.044).

Conclusions: FT3 can be used as an independent predictor of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients. When FT3 is 2.785 pmol/L, the incidence of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients increases significantly.

References

Fadini G, Mehta A, Dhindsa D, Bonora B, Sreejit G, Nagareddy P . Circulating stem cells and cardiovascular outcomes: from basic science to the clinic. Eur Heart J. 2020; 41(44):4271-4282. PMC: 7825095. DOI: 10.1093/eurheartj/ehz923. View

Sardu C, Paolisso P, Sacra C, Mauro C, Minicucci F, Portoghese M . Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study. Diabetes Care. 2019; 42(10):1946-1955. DOI: 10.2337/dc18-2356. View

Hong S, Yul Lee S, Hong M . Clinical Implication of Optical Coherence Tomography-Based Neoatherosclerosis. J Korean Med Sci. 2017; 32(7):1056-1061. PMC: 5461306. DOI: 10.3346/jkms.2017.32.7.1056. View

Cao Q, Jiao Y, Yu T, Sun Z . Association between mild thyroid dysfunction and clinical outcome in acute coronary syndrome undergoing percutaneous coronary intervention. Cardiol J. 2018; 27(3):262-271. PMC: 8015979. DOI: 10.5603/CJ.a2018.0097. View

Hytonen J, Leppanen O, Braesen J, Schunck W, Mueller D, Jung F . Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis. Arterioscler Thromb Vasc Biol. 2016; 36(8):1534-48. DOI: 10.1161/ATVBAHA.115.306962. View

Chambers S, Pathak V, Pedrini E, Soret L, Gendron N, Guerin C . Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl Med. 2021; 10 Suppl 2:S54-S61. PMC: 8560200. DOI: 10.1002/sctm.21-0022. View

Murat S, Yarlioglues M, Celik I, Kurtul A, Duran M, Kilic A . The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease. Clin Appl Thromb Hemost. 2016; 23(3):235-240. DOI: 10.1177/1076029615627340. View

Viswanathan G, Balasubramaniam K, Hardy R, Marshall S, Zaman A, Razvi S . Blood thrombogenicity is independently associated with serum TSH levels in post-non-ST elevation acute coronary syndrome. J Clin Endocrinol Metab. 2014; 99(6):E1050-4. DOI: 10.1210/jc.2013-3062. View

Bhargava M, Lei J, Ingbar D . Nongenomic actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine. Focus on "L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase". Am J Physiol Cell Physiol. 2009; 296(5):C977-9. PMC: 2681374. DOI: 10.1152/ajpcell.00116.2009. View

10.

Su W, Zhao X, Wang M, Chen H, Li H . Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction. J Cardiol. 2018; 72(3):215-219. DOI: 10.1016/j.jjcc.2018.02.013. View

11.

Sasso F, Pafundi P, Marfella R, Calabro P, Piscione F, Furbatto F . Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study. Cardiovasc Diabetol. 2019; 18(1):24. PMC: 6399947. DOI: 10.1186/s12933-019-0826-0. View

12.

Bakker O, Hudig F, Meijssen S, Wiersinga W . Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun. 1998; 249(2):517-21. DOI: 10.1006/bbrc.1998.9174. View

13.

Carrillo-Sepulveda M, Ceravolo G, Fortes Z, Carvalho M, Tostes R, Laurindo F . Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. Cardiovasc Res. 2009; 85(3):560-70. PMC: 3031311. DOI: 10.1093/cvr/cvp304. View

14.

Canpolat U, Turak O, Ozcan F, Oksuz F, Mendi M, Yayla C . Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis. Arch Endocrinol Metab. 2017; 61(2):130-136. PMC: 10118861. DOI: 10.1590/2359-3997000000197. View

15.

Sato Y, Nakamura R, Satoh M, Fujishita K, Mori S, Ishida S . Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res. 2005; 97(6):550-7. DOI: 10.1161/01.RES.0000181431.04290.bd. View

16.

Bonde Y, Breuer O, Lutjohann D, Sjoberg S, Angelin B, Rudling M . Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans. J Lipid Res. 2014; 55(11):2408-15. PMC: 4617142. DOI: 10.1194/jlr.M051664. View

17.

Ahmadi N, Ahmadi F, Sadiqi M, Ziemnicka K, Minczykowski A . Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature. Endokrynol Pol. 2020; 71(5):466-478. DOI: 10.5603/EP.a2020.0052. View

18.

Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F . Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol. 2022; 21(1):77. PMC: 9107763. DOI: 10.1186/s12933-022-01506-8. View

19.

Forini F, Ucciferri N, Kusmic C, Nicolini G, Cecchettini A, Rocchiccioli S . Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach. Int J Mol Sci. 2015; 16(11):26687-705. PMC: 4661832. DOI: 10.3390/ijms161125973. View

20.

Lourbopoulos A, Mourouzis I, Trikas A, Tseti I, Pantos C . Effects of Thyroid Hormone on Tissue Hypoxia: Relevance to Sepsis Therapy. J Clin Med. 2021; 10(24). PMC: 8703810. DOI: 10.3390/jcm10245855. View